Roadmap to Innovation of HTA Methods (IHTAM): insights from three case studies of quantitative methods.

Autor: Jiu L; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Wang J; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Versteeg JW; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Zhang Y; Centre for Health Economics, University of York, York, UK., Liu L; The European Organisation for Research and Treatment of Cancer, Brussels, Belgium., Somolinos-Simón FJ; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain., Tapia-Galisteo J; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.; CIBER-BBN: Networking Research Centre for Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain., García-Sáez G; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.; CIBER-BBN: Networking Research Centre for Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain., Hogervorst MA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Li X; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, The Netherlands., Mantel-Teeuwisse AK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Goettsch WG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; National Health Care Institute, Diemen, The Netherlands.

Publikováno v: International journal of technology assessment in health care [Int J Technol Assess Health Care] 2024 Nov 05; Vol. 40 (1), pp. e49. Date of Electronic Publication: 2024 Nov 05.

A symbolic approach to multiple zeta values at the negative integers

Autor: Moll, V. H., Jiu, L., Vignat, C.

Symbolic computation techniques are used to derive some closed form expressions for an analytic continuation of the Euler-Zagier zeta function evaluated at the negative integers as recently proposed by B. Sadaoui. This approach allows to compute expl

Externí odkaz: http://arxiv.org/abs/1503.04257

Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study.

Autor: Werkman NCC; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, the Netherlands., García-Sáez G; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER)-BBN: Networking Research Center for Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain., Nielen JTH; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands. yannick.nielen@mumc.nl.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, the Netherlands. yannick.nielen@mumc.nl., Tapia-Galisteo J; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER)-BBN: Networking Research Center for Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain., Somolinos-Simón FJ; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain., Hernando ME; Bioengineering and Telemedicine Group, Centro de Tecnología Biomédica, ETSI de Telecomunicación, Universidad Politécnica de Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red (CIBER)-BBN: Networking Research Center for Bioengineering, Biomaterials and Nanomedicine, Madrid, Spain., Wang J; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Jiu L; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Goettsch WG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; National Health Care Institute, Diemen, the Netherlands., van der Kallen CJH; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands., Koster A; Department of Social Medicine, Maastricht University, Maastricht, the Netherlands.; School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, the Netherlands., Schalkwijk CG; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands., de Vries H; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands., de Vries NK; School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, the Netherlands., Eussen SJPM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, the Netherlands.; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands., Driessen JHM; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, the Netherlands., Stehouwer CDA; Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.; Department of Internal Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands.

Publikováno v: Diabetologia [Diabetologia] 2024 Apr; Vol. 67 (4), pp. 690-702. Date of Electronic Publication: 2024 Jan 11.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.